Bicycle Therapeutics plc: COO Jennifer Perry Scott sold 356 shares

What happened

• Jennifer Perry Scott, chief operating officer, sold a total of 356 shares in two reported transactions on Oct 5, 2026: 30 shares at a weighted average price of $3.57 for $107, and 326 shares at $3.78 for $1,232, for total proceeds of $1,339. The filing is an amendment to a prior Form 4.

Key details

• Transaction dates and prices: Oct 5, 2026 — 30 shares @ $3.57 ($107); 326 shares @ $3.78 ($1,232). Footnote notes a price range of $3.56 to $3.57 for the shares covered by that weighted average.
• Shares owned after the transaction: not stated in this filing.
• Footnotes: F1 indicates a "sell to cover" to satisfy statutory tax withholding related to RSU vesting; F3 explains the weighted average price range and offers to provide per-price amounts on request; F4 states one transaction was made pursuant to a Rule 10b5-1 plan adopted Mar 27, 2025; F2 says this amendment corrects overstated numbers in the original Form 4.
• Filing details: amended Form 4 filed Oct 7, 2026; period of report Oct 2, 2026.

Why it may matter

• The filing shows open-market sales; some shares were sold to cover tax withholding and one transaction was under a 10b5-1 plan, as disclosed in the footnotes. A filing does not show why the insider traded or why the company acted.